$5.98
-0.14 (-2.29%)
Halozyme Therapeutics, Inc. (HALO)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

RSS Headlines
Fool UK